Abstract
INTRODUCTION: Points of entry (POE) have an important role in timely national response to infectious diseases threats. However, a guiding framework is lacking for the transition from generic preparedness into optimally specified response for an imminent infectious disease threat, a step called 'operational readiness'. OBJECTIVE: We aim to contribute to the conceptual closure of this preparedness-response gap for infectious disease control at POE by providing content to the operational readiness concept. DESIGN: We first explored the NATO Combat Readiness (NCR) concept for its applicability on infectious disease control at POE, as the military discipline faces the same need of being flexible in preparing for unknown threats. Concepts of the NCR that support the transition into response to a specific threat were integrated into the operational readiness concept. To explore the added value of the concept in practice, we conducted and analysed semistructured interviews of professionals at European POE (n=24) responsible for the early COVID-19 response. RESULTS: Based on the NCR, operational readiness builds on the fact that activating the response capabilities and capacities to a specific threat requires time. For professionals at POE, the transition from generic preparedness into the COVID-19 response led to challenges in specifying response plans, dealing with an overload of information, while experiencing shortages of public health staff. These challenges could be covered within operational readiness by defining the time and the specific staging needed to upgrade response capabilities and capacities. DISCUSSION: We conclude that a guiding framework for operational readiness seems appropriate in relation to the many activities and challenges POE have had to face during the COVID-19 response. Operational readiness is mainly defined by the time dimension required to deploy the response to a specific threat. However, integrating this conceptual framework into practice requires structural and sustainable investments in outbreak preparedness.
Original language | English |
---|---|
Article number | e062960 |
Pages (from-to) | 1-9 |
Number of pages | 9 |
Journal | BMJ Open |
Volume | 13 |
Issue number | 2 |
Early online date | 10 Feb 2023 |
DOIs | |
Publication status | Published - 10 Feb 2023 |
Bibliographical note
Publisher Copyright:© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Funding
This study involves human participants and the study protocol (LCI-455) was reviewed by the Clinical Expertise Centre of the National Institute for Public Health and the Environment. It concluded that the study does not fall under the scope of the Dutch law on medical research involving humans (WMO). This study was conducted under the framework of the EU-HG (grant agreement number: 801493). Participants were aware of the aims and scope of the EU-HG and joined voluntarily. Participants gave informed consent to participate in the study before taking part.
Keywords
- COVID-19
- infection control
- public health
- qualitative research